A clinical-stage biotechnology company focused on developing small‑molecule therapies for neurodegenerative and other serious diseases. The firm has researched treatments targeting microbial contributors to conditions such as Alzheimer’s disease, including its former lead candidate atuzaginstat. Inv...
1 member of Congress has disclosed 4 trades in 71098 (CTRX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-07-09 | Lois Frankel | sell | $1K – $15K |
| 2014-09-18 | Lois Frankel | buy | $1K – $15K |
| 2014-09-15 | Lois Frankel | buy | $1K – $15K |
| 2014-05-23 | Lois Frankel | buy | $1K – $15K |